Skip to main content
Skip to main content

AAP Gateway

Advanced Search »

User menu

  • Login
  • Current Policy
  • Topic/Program Collections
  • Submit Manuscript
  • Alerts
  • Subscribe
  • aap.org

Menu

  • AAP Grand Rounds
  • AAP News
  • Hospital Pediatrics
  • NeoReviews
  • Pediatrics
  • Pediatrics in Review
  • Current AAP Policy
  • Journal CME
  • AAP Career Center
  • Pediatric Collections
  • AAP Journals Catalog

Sections

    • Login
    • Current Policy
    • Topic/Program Collections
    • Submit Manuscript
    • Alerts
    • Subscribe
    • aap.org

    Sign up for Insight Alerts highlighting editor-chosen studies with the greatest impact on clinical care.

    New! Video Abstracts -- brief videos summarizing key findings of new articles

    Know what's next when you read AAP Journals, view the new 2018 Catalog.
    Trainees,
    enter the SOPT Essay Contest for a chance to be published in Pediatrics!

    Advertising Disclaimer »

    Tools and Links

    Pediatrics
    June 2007, VOLUME 119 / ISSUE 6
    From the American Academy of Pediatrics
    FROM THE AMERICAN ACADEMY OF PEDIATRICS

    Electronic Prescribing Systems in Pediatrics: The Rationale and Functionality Requirements

    Council on Clinical Information Technology
    • Article
    • Info & Metrics
    • Comments
    Loading
    Download PDF

    Abstract

    The use of electronic prescribing applications in pediatric practice, as recommended by the federal government and other national health care improvement organizations, should be encouraged. Legislation and policies that foster adoption of electronic prescribing systems by pediatricians should recognize both specific pediatric requirements and general economic incentives required to speed the adoption of these systems. Continued research into improving the effectiveness of these systems, recognizing the unique challenges of providing care to the pediatric population, should be promoted.

    • electronic prescribing
    • clinical decision support
    • pediatrics
    • adverse drug event
    • computer-assisted therapy

    BACKGROUND

    The American Academy of Pediatrics (AAP) is committed to providing the best and safest health care system possible for children.

    Statement of Problem

    The AAP recognizes that the “increasing complexity in patient care in addition to the public's increased scrutiny of the health care system underscores the need to make patient safety an issue of high priority.”1 The AAP supports national efforts to improve patient safety and the recommendations of the Institute of Medicine, the Institute for Safe Medical Practices, the Leapfrog Group, and others who encourage the implementation and use of electronic prescribing (e-prescribing) by physicians as a method to improve patient safety.2,3

    New Information

    E-prescribing systems reduce transcription errors by eliminating illegible prescriptions. Computerized decision support can ensure that prescriptions are checked for drug-drug and drug-allergy interactions before the prescription is written. Dosage calculators can ensure that the correct dose of medication is given on the basis of patient age and weight, and dose-range checking can alert prescribers when doses outside the predetermined ranges are prescribed. Many e-prescribing systems can also check formulary information to determine if a selected medication is covered by a patient's insurance, thereby decreasing patient drug cost and increasing both patient and physician compliance with insurers' preferred-drug prescription programs.5–9 Additional information is available in the accompanying technical report on e-prescribing.4 Research examining the impact of e-prescribing on reducing malpractice claims might result in a commensurate reduction in malpractice liability insurance. Ongoing research will be needed to study the types of errors that may continue to occur after implementation of these systems, including potential new types of errors introduced by the use of e-prescribing systems. This research will guide refinements and improvements to the effectiveness of these systems.8,10,11

    SUMMARY/CONCLUSIONS

    The AAP believes there is sufficient evidence supporting the ability of e-prescribing systems to prevent medical errors and enhance patient care.5–9 However, as with any new technology, the use of these systems may have unintended consequences or novel risks that will need to be monitored and studied over time.

    RECOMMENDATIONS

    1. Federally sponsored research should be conducted to document, in both inpatient and ambulatory (office) settings, specific characteristics of e-prescribing systems that are most beneficial in preventing errors and enhancing patient care. Office processes and methods of implementation that facilitate the effective and efficient use of e-prescribing systems require study.10,12–14

      Accurate data on the incidence and scope of prescribing errors, adverse drug events, and near-miss errors must be available. Regulations should be promoted to facilitate no-fault, anonymous adverse drug event reporting systems as an enabling step toward understanding and intervening to prevent medical errors.1

    2. Because safety for children is paramount, e-prescribing systems used for the care of children should include, at a minimum, pediatric-specific decision support such as weight-based dose calculations and alerts and pediatric drug information and formulation options.3,7,15–17

      When possible, e-prescribing systems should be implemented as part of a robust electronic health record. Such implementations offer advantages well beyond those of freestanding e-prescribing systems. When implementing a stand-alone e-prescribing system, thought should be given to the potential future need to transfer data to, or interface the e-prescribing system with, an electronic health record.

    3. Federal legislation that would unify state regulations and allow for e-prescribing and digital transmission of all prescriptions directly to pharmacies, including those for controlled drugs, should be encouraged.18 The AAP furthermore supports legislation that would require all pharmacies, either directly or through a clearinghouse, to accept digitally transmitted and signed prescriptions. The AAP supports a process for the development of standards for the transmission of digital prescriptions, analogous to the standards-development process under the Health Insurance Portability and Accountability Act for electronic data interchange.

    4. Despite significant benefits to medical and liability insurers, patients, and pharmacy benefit managers,19 e-prescribing applications are an office-practice expense that generates a disproportionately small or no pediatric practice revenue; therefore, the AAP believes adoption of e-prescribing technology would be hastened by the offering of incentives such as pay-for-performance bonuses to practices that routinely use e-prescribing systems that incorporate clinical decision-support alerts.

    5. Because practitioners in rural or low-income areas may face financial and system barriers and, in many cases, do not have access to the network infrastructure to support e-prescribing systems, federal grant and loan programs should be available to support system enhancements such as Internet access and start-up costs.

    IMPLEMENTATION

    Recommendations 1 and 5 (federally funded research and federal grants and loans for e-prescribing systems) may be implemented by providing research grants through the National Library of Medicine, the Agency for Healthcare Research and Quality, the Health Resources and Services Administration, and other federal and local agencies.

    Recommendation 2 (minimum standards for e-prescribing systems) may be implemented by educating providers before purchase of such systems on the required elements through published reports such as the accompanying technical report.4 Such reports should also be shared with standards-development organizations to encourage the inclusion of minimum requirements into the development of these standards.

    Recommendation 3 (federal legislation on e-prescribing) requires action by the collaborative action of the Drug Enforcement Administration to develop standards for the secure digital transmission of category II controlled substances and enable federal legislation that takes precedence over the restrictions placed by state regulations.

    Recommendation 4 (incentives for purchase) should be part of federal and state initiatives to reduce medical errors. Efforts to encourage larger insurers to underwrite such systems should continue—with demonstration projects to document the cost savings to them by the adoption of e-prescribing systems.

    Council on Clinical Information Technology, 2006–2007

    Mark M. Simonian, MD, Chairperson

    Joseph H. Schneider, MD, MBA, Vice Chairperson

    Kristin A. Benson, MD

    Donna M. D'Alessandro, MD

    Mark A. Del Beccaro, MD

    Willa H. Drummond, MD, MS

    George R. Kim, MD

    Michael Leu, MD

    Gregg C. Lund, DO

    Eugenia Marcus, MD

    Alan E. Zuckerman, MD

    Past Council Executive Committee Members

    S. Andrew Spooner, MD, MS, Immediate Past Chairperson

    *Robert S. Gerstle, MD

    Kevin B. Johnson, MD, MS

    Christoph U. Lehmann, MD

    Staff

    Rebecca Marshall

    Footnotes

    • All policy statements from the American Academy of Pediatrics automatically expire 5 years after publication unless reaffirmed, revised, or retired at or before that time.

    • ↵* Lead author

    AAP—American Academy of Pediatrics • e-prescribing—electronic prescribing

    REFERENCES

    1. ↵
      Lannon CM, Coven BJ, Lane France F, et al. Principles of patient safety in pediatrics. Pediatrics.2001;107 :1473– 1475
      OpenUrlAbstract/FREE Full Text
    2. ↵
      Nash DB. The leap to electronic prescribing. P&T.2005;30 :137 . Available at: www.ptcommunity.com/ptjournal/fulltext/30/3/PTJ3003137.pdf. Accessed March 23, 2007
      OpenUrl
    3. ↵
      American Academy of Pediatrics, Committee on Drugs, Committee on Hospital Care. Prevention of medication errors in the pediatric inpatient setting. Pediatrics.2003;112 :431– 436
      OpenUrlAbstract/FREE Full Text
    4. ↵
      American Academy of Pediatrics, Council on Clinical Information Technology. A rationale and functionality requirements for e-prescribing systems in pediatrics [technical report]. Pediatrics.2007;119 (6). Available at: www.pediatrics.org/cgi/content/full/119/6/e1413
    5. ↵
      Bizovi KE, Beckley BE, McDade MC, et al. The effect of computer-assisted prescription writing on emergency department prescription errors. Acad Emerg Med.2002;9 :1168– 1175
      OpenUrlCrossRefPubMedWeb of Science
    6. Bobb A, Gleason K, Husch M, Feinglass J, Yarnold PR, Noskin GA. The epidemiology of prescribing errors: the potential impact of computerized prescriber order entry. Arch Intern Med.2004;164 :785– 792
      OpenUrlCrossRefPubMedWeb of Science
    7. ↵
      Herout PM, Erstad BL. Medication errors involving continuously infused medications in a surgical intensive care unit. Crit Care Med.2004;32 :428– 432
      OpenUrlCrossRefPubMedWeb of Science
    8. ↵
      Tan K, Dear PR, Newell SJ. Clinical decision support systems for neonatal care. Cochrane Database Syst Rev.2005;(2):CD004211
    9. ↵
      Cordero L, Kuehn L, Kumar RR, Mekhjian HS. Impact of computerized physician order entry on clinical practice in a newborn intensive care unit. J Perinatol.2004;24 :88– 93
      OpenUrlCrossRefPubMed
    10. ↵
      Koppel R, Metlay JP, Cohen A, et al. Role of computerized physician order entry systems in facilitating medication errors. JAMA.2005;293 :1197– 1203
      OpenUrlCrossRefPubMedWeb of Science
    11. ↵
      Nebeker JR, Hoffman JM, Weir CR, Bennett CL, Hurdle JF. High rates of adverse drug events in a highly computerized hospital. Arch Intern Med.2005;165 :1111– 1116
      OpenUrlCrossRefPubMedWeb of Science
    12. ↵
      Fernando B, Savelyich BS, Avery AJ, et al. Prescribing safety features of general practice computer systems: evaluation using simulated test cases. BMJ.2004;328 :1171– 1172
      OpenUrlFREE Full Text
    13. Bell DS, Marken RS, Meili RC, et al. Recommendations for comparing electronic prescribing systems: results of an expert consensus process. Health Aff (Millwood).2004:W4– 305–W4–317. Available at: http://content.healthaffairs.org/cgi/reprint/hlthaff.w4.305v1. Accessed June 19, 2006
    14. ↵
      Wang CJ, Marken RS, Meili RC, Straus JB, Landman AB, Bell DS. Functional characteristics of commercial ambulatory electronic prescribing systems: a field study. J Am Med Inform Assoc.2005;12 :346– 356
      OpenUrlAbstract/FREE Full Text
    15. ↵
      Ross LM, Wallace J, Paton JY. Medication errors in a paediatric teaching hospital in the UK: five years operational experience. Arch Dis Child.2000;83 :492– 497
      OpenUrlAbstract/FREE Full Text
    16. Kaushal R, Bates DW, Landrigran C, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA.2001;285 :2114– 2120
      OpenUrlCrossRefPubMedWeb of Science
    17. ↵
      Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med.2003;348 :1556– 1564
      OpenUrlCrossRefPubMedWeb of Science
    18. ↵
      US Department of Justice, Drug Enforcement Administration, Office of Diversion Control. Electronic prescriptions for controlled substances. Available at: www.deadiversion.usdoj.gov/ecomm/e_rx. Accessed June 19, 2006
    19. ↵
      Executive summary—electronic prescribing: toward maximum value and rapid adoption. Washington: eHealth Initiative, 2004. Available at: www.ehealthinitiative.org/initiatives/erx. Accessed June 19, 2006
    • Copyright © 2007 by the American Academy of Pediatrics
    View Abstract
    PreviousNext

     

    Advertising Disclaimer »

    View this article with LENS
    PreviousNext
    Email

    Thank you for your interest in spreading the word on Pediatrics.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Electronic Prescribing Systems in Pediatrics: The Rationale and Functionality Requirements
    (Your Name) has sent you a message from Pediatrics
    (Your Name) thought you would like to see the Pediatrics web site.

    Alerts
    Sign In to Email Alerts with your Email Address
    Citation Tools
    Electronic Prescribing Systems in Pediatrics: The Rationale and Functionality Requirements
    Council on Clinical Information Technology
    Pediatrics Jun 2007, 119 (6) 1229-1231; DOI: 10.1542/peds.2007-0888

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Share
    Electronic Prescribing Systems in Pediatrics: The Rationale and Functionality Requirements
    Council on Clinical Information Technology
    Pediatrics Jun 2007, 119 (6) 1229-1231; DOI: 10.1542/peds.2007-0888
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Print
    PDF
    Insight Alerts
    • Table of Contents
    • Current Policy
    • Early Release
    • Current Issue
    • Past Issues
    • Editorial Board
    • Editorial Policies
    • Overview
    • Open Access
    • Pediatric Collections
    • Video Abstracts
    • Author Guidelines
    • Reviewer Guidelines
    • Submit My Manuscript

    Subjects

    • Current Policy
    • Health Information Technology
      • Health Information Technology
      • Electronic Health Records
    • AAP Policy Collections by Authoring Entities
      • Council on Clinical Information Technology
    Back to top

                

    Copyright (c) 2018 by American Academy of Pediatrics

    International Access »           

    Terms of Use
    Privacy Statement
    FAQ

    AAP Pediatrics